EP0998294A4 - Ganglioside gm3 induced apoptosis of neural cells - Google Patents
Ganglioside gm3 induced apoptosis of neural cellsInfo
- Publication number
- EP0998294A4 EP0998294A4 EP98922465A EP98922465A EP0998294A4 EP 0998294 A4 EP0998294 A4 EP 0998294A4 EP 98922465 A EP98922465 A EP 98922465A EP 98922465 A EP98922465 A EP 98922465A EP 0998294 A4 EP0998294 A4 EP 0998294A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- ganglioside
- induced apoptosis
- neural cells
- neural
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4743097P | 1997-05-22 | 1997-05-22 | |
US47430P | 1997-05-22 | ||
PCT/US1998/010390 WO1998052577A1 (en) | 1997-05-22 | 1998-05-22 | Ganglioside gm3 induced apoptosis of neural cells |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0998294A1 EP0998294A1 (en) | 2000-05-10 |
EP0998294A4 true EP0998294A4 (en) | 2001-02-07 |
Family
ID=21948933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98922465A Withdrawn EP0998294A4 (en) | 1997-05-22 | 1998-05-22 | Ganglioside gm3 induced apoptosis of neural cells |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0998294A4 (en) |
JP (1) | JP2002510291A (en) |
AU (1) | AU7500398A (en) |
CA (1) | CA2290598A1 (en) |
IL (1) | IL133085A0 (en) |
WO (1) | WO1998052577A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL143596A0 (en) | 1998-12-22 | 2002-04-21 | Genentech Inc | Vascular endothelial cell growth factor antagonists and uses thereof |
MXPA05009480A (en) | 2003-03-06 | 2006-02-22 | Neose Technologies Inc | Methods and compositions for the enzymatic synthesis of gangliosides. |
JP4744187B2 (en) * | 2005-05-10 | 2011-08-10 | オリンパス株式会社 | Cell observation device |
WO2010111530A1 (en) | 2009-03-25 | 2010-09-30 | Seneb Biosciences, Inc. | Glycolipids as treatment for disease |
WO2011145622A1 (en) * | 2010-05-17 | 2011-11-24 | 国立大学法人東京工業大学 | Method for detecting gastric cancer |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61227531A (en) * | 1985-03-30 | 1986-10-09 | Sankyo Co Ltd | Antitumor agent |
JPH06145069A (en) * | 1992-11-06 | 1994-05-24 | Nisshin Oil Mills Ltd:The | Vascularization inhibitor containing ganglioside gm3 or its related compound as active component |
EP0728763A1 (en) * | 1994-08-16 | 1996-08-28 | Daikin Industries, Limited | Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4710490A (en) * | 1985-10-01 | 1987-12-01 | Angio Medical Corporation | Compositions containing ganglioside molecules with enhanced angiogenic activity |
-
1998
- 1998-05-22 AU AU75003/98A patent/AU7500398A/en not_active Abandoned
- 1998-05-22 IL IL13308598A patent/IL133085A0/en unknown
- 1998-05-22 WO PCT/US1998/010390 patent/WO1998052577A1/en not_active Application Discontinuation
- 1998-05-22 CA CA002290598A patent/CA2290598A1/en not_active Abandoned
- 1998-05-22 EP EP98922465A patent/EP0998294A4/en not_active Withdrawn
- 1998-05-22 JP JP55062798A patent/JP2002510291A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61227531A (en) * | 1985-03-30 | 1986-10-09 | Sankyo Co Ltd | Antitumor agent |
JPH06145069A (en) * | 1992-11-06 | 1994-05-24 | Nisshin Oil Mills Ltd:The | Vascularization inhibitor containing ganglioside gm3 or its related compound as active component |
EP0728763A1 (en) * | 1994-08-16 | 1996-08-28 | Daikin Industries, Limited | Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor |
Non-Patent Citations (4)
Title |
---|
DATABASE WPI Section Ch Week 198647, Derwent World Patents Index; Class B03, AN 1986-308516, XP002149606 * |
DATABASE WPI Section Ch Week 199425, Derwent World Patents Index; Class B03, AN 1994-206348, XP002149607 * |
MERZAK ET AL.: "Gangliosides Modulate Proliferation, Migration, and Invasiveness of Human Brain Tumor Cells in vitro", MOL. CHEM. NEUROPATHOL., 1995, pages 121 - 135, XP000941051 * |
See also references of WO9852577A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU7500398A (en) | 1998-12-11 |
EP0998294A1 (en) | 2000-05-10 |
WO1998052577A1 (en) | 1998-11-26 |
CA2290598A1 (en) | 1998-11-26 |
JP2002510291A (en) | 2002-04-02 |
IL133085A0 (en) | 2001-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0003995A2 (en) | Absorption of minerals by intestinal cells | |
EP0937095A4 (en) | Targeted cytolysis of cancer cells | |
HUP0002317A3 (en) | Self-regulated apoptosis of inflammatory cells by gene therapy | |
GB2301441B (en) | Hexacyanoferrate modified electrodes | |
IL133085A0 (en) | Ganglioside gm3 induced apoptosis of neural cells | |
ZA959846B (en) | Enzyme prodrug therapy | |
HUP0100776A3 (en) | Self-regulated apoptosis of inflammatory cells by gene therapy | |
AU2002300727A1 (en) | Ganglioside GM3 Induced Apoptosis of Neural Cells | |
TW333828U (en) | Roller type massager structure | |
ZA9811600B (en) | SAG: sensitive to apoptosis gene | |
EP1034294A4 (en) | Enzymatic synthesis of gangliosides | |
TW378759U (en) | Improved structure of the glasses | |
TW312301U (en) | Improved structure of earmask | |
TW319017U (en) | Improved structure of mousetraps | |
TW323793U (en) | Improved structure of level rule | |
GB9709408D0 (en) | Neural cultures | |
TW361390U (en) | New design of roller structure | |
TW316466U (en) | Structure of hangtag | |
TW314733U (en) | Structure of hairclip | |
GB9523714D0 (en) | Enzyme prodrug therapy | |
TW295824U (en) | Dual purpose structure of glasses case | |
TW312347U (en) | Improved structure of clock glass | |
PL106308U1 (en) | Cupping glass | |
TW335032U (en) | Improved roller structure | |
TW312131U (en) | Improved structure of earflaps |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19991221 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20001227 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20031127 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20031202 |